US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US Pulse Oximeters Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$494.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.16 Bn | — | — |
| 2025 (base) | $1.20 Bn | +$45.2 Mn | — |
| 2026 (forecast) | $1.25 Bn | +$46.9 Mn | +3.9% |
| 2027 (forecast) | $1.30 Bn | +$48.8 Mn | +8% |
| 2028 (forecast) | $1.35 Bn | +$50.7 Mn | +12.2% |
| 2029 (forecast) | $1.40 Bn | +$52.6 Mn | +16.5% |
| 2030 (forecast) | $1.46 Bn | +$54.7 Mn | +21.1% |
| 2031 (forecast) | $1.51 Bn | +$56.8 Mn | +25.8% |
| 2032 (forecast) | $1.57 Bn | +$59.0 Mn | +30.7% |
| 2033 (forecast) | $1.63 Bn | +$61.3 Mn | +35.8% |
| 2034 (forecast) | $1.70 Bn | +$63.7 Mn | +41.1% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Pulse oximeters clip on a finger or are worn on the body to measure blood oxygen and heart rate.
Key segments of the pulse Oximeters market include product (Fingertip Oximeters, Handheld Oximeters and Wearable Oximeters) and setting (Hospitals, Home and Clinics).
Rising rates of sleep apnea, sinus disease and hearing loss, an ageing population and less invasive treatments are driving the pulse Oximeters market.
Home-based diagnosis, smaller connected devices and office-based procedures give the pulse Oximeters market room to grow.
Device costs, patients stopping therapy, limited reimbursement and supply issues after recalls hold back the pulse Oximeters market.
The pulse Oximeters market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how pulse Oximeters products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Pulse Oximeters right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
US · 3 shared keywords
US · 3 shared keywords
US · 3 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
Digital Health · US
Digital Health · US
Pharmaceuticals · US
Healthcare Services · US
Digital Health · US
Pharmaceuticals · US